NCT05458167

Brief Summary

A randomised controlled crossover pilot study to evaluate safety and efficacy of a digital insulin bolus calculator with a physical activity module

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable diabetes

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable diabetes

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 11, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 14, 2022

Completed
9 months until next milestone

Study Start

First participant enrolled

April 3, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 3, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 3, 2024

Completed
Last Updated

June 7, 2024

Status Verified

June 1, 2024

Enrollment Period

1 year

First QC Date

July 11, 2022

Last Update Submit

June 6, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time-in-range of Hedia Diabetes Assistant bolus calculator with physical activity module

    To compare the efficacy of the physical activity module as part of the Hedia Diabetes Assistant bolus calculator compared to the participants' habitual diabetes management during a 24-hour period starting one hour before exercise in adults with type 1 diabetes mellitus in terms of time-in-range (blood glucose 3.9-10.0 mmol/l).

    24-hour period starting one hour before exercise

Secondary Outcomes (3)

  • Hypoglycemic events of Hedia Diabetes Assistant bolus calculator with physical activity module

    24-hour period starting one hour before exercise

  • Time-above-range of Hedia Diabetes Assistant bolus calculator with physical activity module

    24-hour period starting one hour before exercise

  • Time-below-range of Hedia Diabetes Assistant bolus calculator with physical activity module

    24-hour period starting one hour before exercise

Other Outcomes (4)

  • Glycemic variability of Hedia Diabetes Assistant bolus calculator with physical activity module

    24-hour period starting one hour before exercise

  • Daily insulin requirement of Hedia Diabetes Assistant bolus calculator with physical activity module

    24-hour period starting one hour before exercise

  • Daily correctional actions of Hedia Diabetes Assistant bolus calculator with physical activity module

    24-hour period starting one hour before exercise

  • +1 more other outcomes

Study Arms (2)

Device: Hedia Diabetes Assistant with physical activity module.

EXPERIMENTAL

The participants will take part in a 45-minute moderate-intensity exercise bout on a stationary ergometer bike. Participants will use the Hedia Diabetes Assistant bolus calculator with the physical activity module (intervention) during a 24-hour period starting one hour before the bout of exercise.

Device: Hedia Diabetes Assistant bolus calculator with a physical activity module

Usual treatment

ACTIVE COMPARATOR

The participants will take part in a 45-minute moderate-intensity exercise bout on a stationary ergometer bike. Participants will use their habitual diabetes management approach during a 24-hour period starting one hour before the bout of exercise (control).

Device: Hedia Diabetes Assistant bolus calculator with a physical activity module

Interventions

Hedia Diabetes Assistant bolus calculator with a physical activity module is a software device that calculates an insulin bolus based on blood glucose, carbohydrates and physical activity.

Device: Hedia Diabetes Assistant with physical activity module.Usual treatment

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Signed informed consent.
  • Ability to understand, speak and read Danish fluently.
  • Diagnosis of type 1 diabetes mellitus for ≥12 months.
  • Age between ≥18 and \<60 years.
  • Minimum one measurement of HbA1c between 6.0 to 8.6 % (42 to 70 mmol/mol) within the last four months. If several measurements, then it is the latest one that counts.
  • Body mass index (BMI) between ≥18.5 and \<30 kg/m2.
  • Ability to use an Apple® (iOS version 13 and up) or Android® (Android version 8.0 and up) smartphone.
  • Treated with the same pen-based insulin regimen with basal insulin (insulin glargine, degludec, or detemir) and meal time insulin (insulin aspart, lispro, glulisine) for at least the three preceding months.
  • Patients who can perform 45 min. of exercise at moderate intensity on an ergometer bike (investigator assessment).
  • If female participants of childbearing potential; willing to have a pregnancy test performed and to use a highly effective method of contraception.

You may not qualify if:

  • Already using Hedia Diabetes Assistant.
  • Use of human insulin or premixed insulin.
  • Blood pressure \> 180/105 mmHg.
  • Treatment with sodium-glucose transporter 2-inhibitors, glucagon-like peptide 1 receptor agonists, or glucocorticoids.
  • Job situation entailing night shifts.
  • Fever.
  • A mental state impeding compliance with the protocol.
  • Expected non-compliance with the protocol at the discretion of the principal investigator.
  • Pregnancy.
  • Breast-feeding.
  • Dialysis therapy or eGFR \< 60 ml/min.
  • Patients diagnosed with claudicatio intermittens, heart failure, ischaemic heart disease or stroke.
  • Patients prescribed with beta blockers.
  • Abuse of alcohol or drugs in the past two years.
  • On-going participation, or participation within the last 3 months, in an organised clinical study in which participants received study medication (investigator assessment).
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

North Zealand Hospital - Hillerød

Hillerød, 3400, Denmark

Location

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Anne Østerskov

    Hedia ApS

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 11, 2022

First Posted

July 14, 2022

Study Start

April 3, 2023

Primary Completion

April 3, 2024

Study Completion

April 3, 2024

Last Updated

June 7, 2024

Record last verified: 2024-06

Locations